跳至主要内容
临床试验/NCT05092516
NCT05092516进行中(未招募)不适用

Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Cognitive Post-acute Sequelae of COVID-19 (PASC)

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2022年6月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
31
试验地点
2
主要终点
Change in EEG P300 event-related potential

研究概览

简要总结

The main goal of this study is to improve dysexecutive symptoms (e.g., sustained attention, processing speed) in patients exhibiting post-acute sequelae of COVID-19 (PASC) through home-based transcranial direct current stimulation (tDCS), a noninvasive method that uses low intensity electric currents delivered to the brain through stimulation electrodes on the scalp.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ability to provide informed consent
  • A diagnosis of PASC as indicated by past COVID-19 infection, and persistent symptoms, including 'brain fog', confusion, short-term memory deficits, trouble concentrating, delirium, difficulties in multitasking.

排除标准

  • History of epilepsy
  • Metallic implants in the head and neck,
  • Brain stimulators
  • Pacemakers
  • Pregnancy
  • Active substance dependence (except for tobacco)
  • Premorbid major neurological illness
  • Severe mental illness (e.g., bipolar disorder, schizophrenia)
  • Attention Deficit Hyperactivity Disorder

研究组 & 干预措施

Sham tDCS

Sham Comparator

This group will receive daily sham stimulation to the left dorsolateral prefrontal cortex for 4 weeks through a home-based tDCS device in remotely-supervised 30-min sessions.

干预措施: Sham tDCS (Device)

Active tDCS

Experimental

This group will receive daily active stimulation (2 mA) to the left dorsolateral prefrontal cortex for 4 weeks through a home-based tDCS device in remotely-supervised 30-min sessions.

干预措施: Active tDCS (Device)

结局指标

主要结局

Change in EEG P300 event-related potential

时间窗: 8 weeks

EEG P300 amplitudes time-locked to the incongruent trials of the Eriksen Flanker Task will be assessed at four time points before, during, and after the 4-week intervention.

Change in inhibitory control

时间窗: 8 weeks

Performance during the incongruent trials of the Eriksen Flanker Task will be assessed at four time points before, during, and after the 4-week intervention.

Change in processing speed

时间窗: 8 weeks

Reaction time during the incongruent trials of the Eriksen Flanker Task will be assessed at four time points before, during, and after the 4-week intervention.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hamdi Eryilmaz, PhD

Assistant Professor

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验